Targeting AS Damage

Bone formation in ankylosing spondylitis during anti-tumour necrosis factor therapy imaged by 18 F-fluoride positron emission tomography

academic.oup.com

<p>Whether TNF inhibitors prevent structural damage in ankylosing spondylitis remains a controversial…
nature.com

The RAPID-axSpA study of ankylosing spondylitis…
rheumnow.com

Limited radiographic progression and sustained reductions in MRI inflammation in patients with axial Spondyloarthritis: 4-year imaging outcomes from the RAPID-axSpA phase III randomised trial

ard.bmj.com

For patients with ankylosing spondylitis, secukinumab may reduce radiographic progression and remain effective in the long-term.
rheumatologyadvisor.com

Anti-IL17 Benefits Persist in Spine Disease

Rapid responses seen for secukinumab in ankylosing spondylitis
medpagetoday.com

No Comments Yet.

Leave a comment